“三生制药”含量高的ETF来了!

格隆汇
20 May

格隆汇5月20日|创新药爆了!三生制药引爆港股通创新药ETF、港股创新药50ETF、恒生创新药ETF… 中国创新药出海又有大消息。2025年5月20日,中国生物医药行业迎来历史性时刻——三生制药自主研发的PD-1/VEGF双抗药物SSGJ-707,以“首付款12.5亿美元、潜在总金额60亿美元”的价格,将海外权益卖给辉瑞。 “三生制药”含量高的ETF一览:

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10